Royal BodyCare is conducting an ongoing series of laboratory and clinical studies designed to evaluate the nutritional characteristics and benefits of Microhydrin® as a mineral antioxidant. Th following is a brief summary of the results of studies completed as of December 31, 1998.

Because this data may be included in papers submitted for publication in peer reviewed journals, and because their work load does not permit time to answer numerous inquiries, scientist conducting the studies asked RBC not to publish their names and institutions. However, the complete reports are on file at Royal BodyCare headquarters, and will be available, for review b appropriate government regulators.

Tests on Microhydrin® were conducted using electron spin resonance techniques (ESR) by scientist who specializes in the evaluation of antioxidants at a major university. The following is quoted from the test report:

"We have made a thorough investigation of the antioxidant activity of Microhydrin® by several experimental methods." "Hydroxyl radical scavenging activity was found in two different Microhydrin® preparations provided."

"Our conclusions are that Microhydrin® has antioxidant activity towards hydroxyl radical Hydroxyl radicals are among the most dangerous of oxygen free radicals that occur in biologic systems. They are the same types of radicals that can be produced by exposure to ionizing radiation. Therefore it can be stated that Microhydrin® has antioxidant activity in this regard."

Tests on Microhydrin® were conducted by a scientist who also specializes in the evaluation of antioxidants at a separate major university. The following is quoted from the test report:

"When assayed in the 'standard' assay for super oxide dismutase activity based upon the reduction of cytochrome c by xanthine (see J. Biol. Chem. 244: 6049-6055, 1969), Microhydrin® showed two characteristics:

"When assayed with an alternative method based on the ability of superoxide to oxidize epinephrine to adrenochrome, Microhydrin® also showed its ability to scavenge the superoxide radical and inhibit the process."

Leonard Smith, MD, Medical Director for RBC, conducted the Heidelberg Test on himself at a clinic in order to determine the effect of Microhydrin® on stomach acid. The Heidelberg Test utilizes a tiny radio transmitter in a capsule, which measures and transmits the pH of it environment.

Dr. Smith swallowed the capsule and waited 10 minutes to establish the baseline pH. Th radio transmitter indicated a pH of 1.0 typical of stomach acid. He then swallowed 2 Microhydrin capsules with a small amount of water. According to the technician, a momentary blip in the pH was a normal indication of water reaching the stomach. The stomach normally empties in about 30 to 4 minutes. After 45 minutes the pH rose to 6 indicating, according to the technician, that the capsule had reached the small intestine. The conclusion from this test was that Microhydrin® in its vegetable capsule, when taken with water, does not release significantly while in the stomach, and does n alkalinize stomach acid.

Five subjects were given six Microhydrin® per day for five days. An independent clinic laboratory analyzed lipid peroxides using HPLC methods on each subject before and after Microhydrin® supplementation. The Medical Doctor conducting the trial observed no substantial change in lipid peroxides and no adverse side effects during the supplementation period.

A controlled clinical trial showed that in eight normal adult subjects, seven of the nine Biological Terrain Assessment parameters improved. Saliva pH, saliva rH2, blood resistivity, and urine resistivity showed statistically significant improvement (p _ 0.05) for these eight subjects after 18 days of supplementation with 4 Microhydrin® per day on a schedule of one in the morning, two at midday and one in the evening. Three other parameters (urine pH, urine rH, and saliva resistivity) also showed improvement over the 18-day supplementation period when their average changes were calculated.

Blood pH and blood rH2 were the only parameters that did not change during the supplementation period. These values may not change as readily due to the heterogeneous and stable nature of blood. The nutritionists and physicians who monitored the study with Biological Terrain Assessment results and other clinical data observed no adverse side effects in this group during the supplementation period.